Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03420742 |
|---|---|
| Brief Title: | A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors |
| First Submitted : | January 29, 2018 |
| First Submitted that Met QC Criteria : | January 29, 2018 |
| First Posted : | February 5, 2018 |
| Results First Submitted : | April 22, 2022 |
| Results First Submitted that Met QC Criteria : | April 22, 2022 |
| Results First Posted : | January 27, 2023 |
| Last Update Submitted that Met QC Criteria : | April 22, 2022 |
| Last Update Posted : | January 27, 2023 |